The International Clinical Studies Support Center (ICSSC) was created by DMID/NIAID to provide a wide range of support services to clinical investigators who are conducting international research funded by DMID. The ICSSC is housed at FHI 360, an organization with over 30 years experience conducting clinical research in more than 80 countries.
ICSSC training events, consultation, and assistance are available in a variety of areas including:
Who can request assistance?
Scientists funded by NIAID/DMID who are conducting research at foreign sites
How to request assistance:
Principal Investigators may submit a request for assistance online at this ICSSC website (www.icssc.org), or may request assistance through their Program Officers.
This Funding Opportunity Announcement (FOA) encourages applications from organizations/institutions in eligible foreign countries that propose research related to infectious diseases that are of interest/importance to that country.
Letters of Intent due date: April 22, 2017
Open date/Earliest submission date: April 22, 2017
Application due date(s):
*This information is taken directly from NIAID email announcements
An experimental dengue vaccine developed by NIAID researchers is now being tested in a large-scale clinical trial in Brazil.
Multiple datasets from human immune profiling studies are now publicly available on ImmuneSpace, a new NIAID-funded online resource where users can explore, analyze, and visualize data from the Human Immunology Project Consortium (HIPC).
The ImmuneSpace platform offers users state-of-the-art computational tools to explore studies, integrate and analyze data across assays, and perform custom analyses.